A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers is a research paper published in Oncogene (2021). On theSindex it has a DataRank of 0.524. It has been cited 32 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.524
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Science Foundation
Grant: 1842386
Data Science Program with Career Support and Connections to Industry
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: 2P30CA016520
Cancer Research UK
Grant: C13329/A21671
NIGMS NIH HHS
Grant: SC1 GM121182
NCI NIH HHS
Grant: P30 CA016520
NCI NIH HHS
Grant: R00 CA222554
Cancer Research UK
Grant: DRCRPG-May21\100002
National Institutes of Health
Grant: 2P30CA016520-35
Abramson Cancer Center Support Grant
National Institutes of Health
Grant: 5R00CA222554-05
Analysis of tumor-stroma signaling that mediates HER2-therapy resistance in breast cancer
National Institutes of Health
Grant: 3SC1GM121182-07S1
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
Wellcome Trust
Wellcome Trust
FWCI
1.78
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals